These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 14619697)

  • 21. Dimensional changes, gel layer evolution and drug release studies in hydrophilic matrices loaded with drugs of different solubility.
    Efentakis M; Pagoni I; Vlachou M; Avgoustakis K
    Int J Pharm; 2007 Jul; 339(1-2):66-75. PubMed ID: 17408891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
    Miranda A; Millán M; Caraballo I
    Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A model for the drug release from a polymer matrix tablet--effects of swelling and dissolution.
    Borgquist P; Körner A; Piculell L; Larsson A; Axelsson A
    J Control Release; 2006 Jul; 113(3):216-25. PubMed ID: 16797098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric floating matrix tablets: design and optimization using combination of polymers.
    Prajapati ST; Patel LD; Patel DM
    Acta Pharm; 2008 Jun; 58(2):221-9. PubMed ID: 18515232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mucoadhesive oral tablets--a modern dosage form with controlled drug release].
    Dostálová M; Rabisková M
    Ceska Slov Farm; 2000 Mar; 49(2):55-61. PubMed ID: 10953444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
    Fuertes I; Miranda A; Millán M; Caraballo I
    Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug.
    Kranz H; Guthmann C; Wagner T; Lipp R; Reinhard J
    Eur J Pharm Sci; 2005 Sep; 26(1):47-53. PubMed ID: 15953712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thermoplastic granulation as an alternative method for the preparation of hydrophilic-lipophilic oral matriix tablets].
    Dvorácková K; Rabisková M; Masteiková R; Vocilková L
    Ceska Slov Farm; 2007 Jun; 56(3):129-34. PubMed ID: 17867525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preparations of acetylsalicylic acid sustained-release tablets on hydrophilic matrix forms].
    Süss W; Bruder K
    Pharmazie; 1987 Jul; 42(7):457-8. PubMed ID: 3671471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmaceutical technology of Cordaflex tablets].
    Erdös S
    Acta Pharm Hung; 1996 Jan; 66(1):41-5. PubMed ID: 8714364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
    Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
    Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
    Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
    Bravo-Osuna I; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2008 May; 69(1):285-93. PubMed ID: 17997292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
    Li FQ; Hu JH
    Yao Xue Xue Bao; 2004 May; 39(5):389-91. PubMed ID: 15338886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Release of water-soluble active agents from polymer embeddings. 2. The significance of the manufacturing process-dependent macrostructure of the embedded dosage from an active agent release].
    Süss W
    Pharmazie; 1983 Sep; 38(9):601-7. PubMed ID: 6647532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-beta-cyclodextrin.
    Corti G; Cirri M; Maestrelli F; Mennini N; Mura P
    Eur J Pharm Biopharm; 2008 Feb; 68(2):303-9. PubMed ID: 17616379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydrophilic matrix sustained release systems based on polysaccharide carriers.
    Melia CD
    Crit Rev Ther Drug Carrier Syst; 1991; 8(4):395-421. PubMed ID: 1769067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics.
    Karavas E; Georgarakis E; Bikiaris D
    Eur J Pharm Biopharm; 2006 Aug; 64(1):115-26. PubMed ID: 16675210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.